Riskpilot← Back to searchSign inGet full accessMediconnex AB
ABActiveOrg 5590618806Wholesale of other food · NACE 4638Est. 20160 employees
Revenue 2024
—
EBITDA margin
—
Equity ratio
—
Financial strength
Net profit 2024
—
0 employees
| Revenue | — | — |
| EBITDA | SEK 0 | — |
| Net profit | — | — |
| Total assets | — | — |
| Equity | — | — |
| Employees | 0 | — |
Legal name
Mediconnex AB
Org number
5590618806
Legal form
Aktiebolag
NACE code
4638 · Wholesale of other food
Founded
9 maj 2016
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Företaget ska driva handel och utveckling med läkemedel, medicinteknisk utrustning, kosttillskott, naturmedel, och kosmetik, förvalta värdepapper, samt bedriva annan därmed förenlig verksamhet. Företaget ska också driva konsultationer inom företagsekonomi, organisation, marknadsföring, investering samt därmed förenlig verksamhet.
Address
Email
wxjstudio@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 057 | 0 | 0 | 0 | — |
| Staff expenses | — | — | — | — | — |
| EBITDA | 177 | −10 | −53 | −1 | 0 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | — |
| EBIT | 177 | −10 | −53 | −1 | 0 |
| Net financials | −2 | −1 | — | — | — |
| Profit before tax | 122 | −11 | −1 | −1 | 0 |
| Tax | −11 | −0 | −0 | −0 | — |
| Net profit | 111 | −11 | −1 | −1 | — |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 175 | 171 | 63 | 68 | — |
| Equity | 89 | 78 | 77 | 53 | — |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 34 | 41 | 14 | 8 | — |
| Total debt | 34 | 41 | 14 | 8 | — |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20202024
Equity ratio
0.0%
This company
38.2%
Market median
-100% vs market
20202024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20202024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
-1.00×
This company
0.62×
Market median
+261% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MX Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
YL | Deputy Board Member | 2021 |
| Former (3) | ||
| Deputy Board Member | 2020 – 2021 | |
| Board of Directors | 2020 – 2021 | |
| Chairman | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Mediconnex AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Maggie Xiangjun Wang | Chief Executive Officer | 0 companies |
| Bengt Stefan Wivegg | Deputy Board Member | 0 companies |
| Aster Girmay Nuguse Weldemichael | Board of Directors | 0 companies |
| Guojian SHI | Chairman | 0 companies |
| Yuan Lin | Deputy Board Member | 0 companies |